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ABSTRACT 
The aim of this research was to develop and evaluate a matrix type of transdermal drug delivery system containing Verapamil 
Hydrochloride. The series of formulations containing Verapamil Hydrochloride were formulated by using different polymers like HPMC 
(hydrophilic), CAP (hydrophobic) and EC (hydrophobic) in different ratios by solvent evaporation technique. Propylene glycol and Dibutyl 
phthalate were used as plasticizers. The 20% and 40% of DMSO is used as the penetration enhancer. Formulated transdermal patches were 
physically evaluated for thickness, weight variation, drug content, flatness, tensile strength, folding endurance, and water vapour 
transmission rate. The in-vitro drug release study was carried out by using Franz diffusion cell. The data obtained from release study shows 
increased percentage of drug permeated in 20% of DMSO containing formulation than 40% of DMSO containing formulation. Drug 
permeation is enhanced in the formulation containing high concentration of HPMC (VH1). The VH2 and VH6 helped in maintaining the rate 
of release at a constant level (20% DMSO). But in case of 40% DMSO is used as the concentration of CAP increases the rate of permeation 
increases. Skin irritation study does not show any irritation on the skin of rabbit. There is no possible interaction between drug and 
polymers in FITR as well as DSC. XRD of selected formulation shows that drug present in the formulation is in crystalline form. 
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INTRODUCTION  
The most preferred route of administration is oral route 
but oral route have some disadvantages like hepatic first 
pass metabolism, poor bioavailability and tendency to 
produce rapid blood level spikes and this leads to frequent 
dosing so to overcome these drawbacks there is a need for 
the development of new drug delivery system.1 
TDDS are topically administered medicaments. Patches 
that deliver drugs for systemic effects at a predetermined 
and controlled rate. Transdermal patches are flexible 
pharmaceutical preparation of changeable sizes, 
containing, one or more active ingredients. Patches are 
intended to be applied to the unbroken skin in order to 
convey the active components to the systemic circulation 
after passing through the skin barriers.  
Transdermal delivery not just provides controlled, 
continuous administration of the drug, but also allows 
constant input of drugs with short biological ½ life and 
eliminates pulsed entry into systemic circulation, which 
often causes adverse side effects. Thus, a variety of forms of 
Novel drug delivery system such as TDDS, CRS, 
Transmucosal delivery systems etc. emerged2. Which 
improves the physiological and pharmacological response, 
avoiding the fluctuation in drug levels, inter and intra 
patient variations1. 
The main goal of transdermal drug delivery system is to 
maximize the flux through the skin into the systemic 
circulation and simultaneously minimize the retention and 
metabolism of the drug in the skin3. 
Verapamil hydrochloride is an L-type calcium channel 
blocker of the phenylalkylamine class. Given orally, 90 
to100% of verapamil is absorbed, but due to high first-pass 
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metabolism, bioavailability is much poorer (10 to35%). It 
is 90% bound to plasma proteins and it has a volume of 
distribution of 3 to 5 l/kg. It gets metabolized in the liver 
into 12 inactive metabolites. 70% of metabolites get 
excreted in the urine and 16% in feces; 3 to 4% is excreted 
unaffected in urine. Metabolism is a nonlinear dependence 
between plasma concentration and dosage. Onset of action 
is 1 to 2 hours after oral dosage. t 1/2 is 2.8 to 7.4 hours.4  
Hence, the proposed work involves the formulation and 
evaluation of transdermal drug delivery systems 
containing verapamil hydrochloride for the treatment of 
patients during hypertension and angina pectoris. 
MATERIALS AND METHODS 
Materials: Verapamil Hcl is received as gift sample from 
Micro labs Bangalore, Karanataka. Hydroxy propyl methyl 
cellulose (HPMC), Cellulose acetate phthalate and ethyl 
cellulose were purchased from Central drug house (p) ltd, 
Yarrow chem. Products, and Loba Chemicals pvt. Ltd. 
Mumbai, India. Di-butyl phthalate, propylene glycol, 
chloroform, dimethyl sulfoxide are purchased from  Loba 
Chemicals pvt. Ltd. Mumbai, Finar chemical ltd and Central 
drug house (p) ltd . All other solvents and reagents were 
used as analytical grade. 
 
Table 1:    Formulation table for Verapamil HCl 
Ingrediens VH1 VH2 VH3 VH4 VH5 VH6 VH7 VH8 VH9 VH10 VH11 VH12 
Verapamil 
HCl mg 100 100 100 100 100 100 100 
 
100 100 100 100 100 
HPMC mg 500 - - 200 200 - 500 - - 200 200 - 
CAP mg  - 500 - 300 - 200 - 500 - 300 - 200 
EC mg - - 500 - 300 300 - - 500 - 300 300 
DBP/PG 
(w/v) 
40% 
PG 
60%
DBP 
40%
DBP 
50%D
BP 
40%DB
P 
40%DB
P 
40%PG 60%D
BP 
40%
DBP 
50% 
DBP 
40% 
DBP 
40% 
DBP 
Alcohol/ 
CHCl3 ml 10 10 10 10 10  10  10 10 10 10 10 10 
DMSO 20% 20% 20% 20% 20% 20% 40% 40% 40% 40% 40% 40% 
 
Preparation of transdermal patch 
Transdermal patches containing Verapamil HCl was 
prepared by using mercury substrate method using 
different grade of polymers. The polymers used were Ethyl 
cellulose, Cellulose acetate phthalate and Hydroxy propyl 
methyl cellulose were taken in required quantity as shown 
in the table. About 10ml of chloroform or ethanol is added 
to solubilztion of polymers and kept it aside for few 
minutes for swelling of polymers. And after complete 
solubilization of the polymers in mixture of solvent, 
weighed quantity of Verapamil HCl was further added to 
the polymeric solution and mixed well. Finally required 
quantity of dibutyl phthalate or propylene glycol is added 
to the mixture, and vertexed. It was set aside cleaned 
petridish containing mercury and kept it aside for solvent 
evaporation. The rate of solvent evaporation is controlled 
by inverting a glass funnel over the petridish. After 
overnight, the dried films were taken out and stored in a 
desiccators. 
Evaluation of transdermal patches 
Physical Appearance: All the formulated transdermal 
patches were visually examined for colour, flexibility, 
homogeneity and smoothness5. 
 Thickness:  Thickness of the patches were calculated at 5 
different randomly selected spots on films using a screw 
gauge (micrometer). Such determination was performed 
for each formulation5.  
Weight Uniformity: Each patch was weighed separately 
and average weight of three films was determined6.  
Folding endurance: A strip of specific are is to be cut 
evenly and repeatedly folded at the same place till it broke. 
The number of times the film could be folded at the same 
place without breaking gave the value of the folding 
endurance7.  
Determination of Drug content: A sample of 1 sq.cm of 
the patch was cut and weighed precisely. Each sample was 
subjected to dissolve in 100 ml of 7.4 phosphate buffer 
solution and magnetically stirred for 24 hrs. The 
absorbance of the solution is determined by using UV-VIS 
spectrophotometer at respective nm. The total drug 
present in the patch of Verapamil HCl was determined8.   
Fourier transform infrared spectrometry: The pure 
drug and a mixture of drug with the selected polymers 
were taken for the interaction study. For that pure drug 
and mixture of drug with the selected polymers were 
mixed separately with IR grade KBr/NaCl in the ratio of 
1:100. The base line correction was done by using dried 
KBr/ NaCl. IR spectra of the mixture were taken over a 
wave number range of 4000 to 400 cm-1. The IR spectra of 
the pure drug and mixture of drug and polymers were 
carried out separately. Then obtained IR spectra were 
investigated for possible interaction between polymer and 
drug9.  
Scanning electron microscopic studies: The films were 
mounted in the SEM instrument by using double sided 
adhesive tape. The coated films were observed under SEM 
(JEOL/EO, JSM- 6390, Kyoto, Japan) at the required 
magnification at room temperature. The specific 
acceleration voltage was used along with the secondary 
electron image as a detector to get images of the 
formulation by which surface morphology of the patches 
were determined. 
X-Ray diffraction studies: The spectra of the sample was 
recorded by using Rigaku Miniflex II , X-ray diffractometer 
with Cu-NF filtered CuK radiation. Quartz was used an a 
internal standard for calibration. The powder x- ray 
diffractometer was to a digital graphical assembly and 
computer with Cu-NF 25KV/20 mA   tube as CuK radiation 
source in the 2θ range 0-500C. 
 Differential scanning calorimetric analysis: The 
samples were heated from 0-300oC at a heating rate of 
10oC/min under argon or nitrogen atmosphere using a 
micro calorimeter (DuPont-9900, USA) and then thermo 
grams were obtained.  
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Water vapour transmission: For these study vials of 
equal diameter was used as permeation cell. These cells 
were thoroughly washed and dried, about one gram of 
calcium chloride was taken in vials and the films were 
tightly attached over the brim with the help of adhesive. 
Then the vials were subjected to weighing. The accurately 
weighed vials are placed in the desiccators containing 
saturated solution of potassium chloride (200ml). The vials 
were taken out and weighed after every 24 hrs up to 7 days 
of storage. From the increased in the weights, the rate of 
water vapour transmission was calculated. 
Permeation Studies: Thermostatically controlled Franz 
diffusion cell assembly was used for carrying out the 
permeation studies. Excised rat epidermis was placed over 
the receptor compartment with dermis facing towards 
donor compartment. Samples were withdrawn from the 
sampling port at predetermined intervals and the same 
quantity of fresh buffer was replaced at the same time to 
maintain sink conditions. Phosphate buffer pH 7.4 was 
filled in receptor compartment. The temperature was 
maintained at 37±2 °C and stirring rate was 100 rpm. The 
diffusion studies were carried out for 24 hrs. Samples were 
analyzed spectro photometrically at absorption maxima of 
278 nm 
Skin Irritation study: Skin irritation test is carried out on 
healthy rabbits (average weight 1.2 to 1.5 kg). The dorsal 
surface (50cm2) of the rabbit is to be cleaned by removing 
the hair from the dorsal surface by shaving. The prepared 
formulations can be applied over the skin. The patch is to 
be detached after 24 hr and the skin is to be observed for 
irritation and oedma.  
Stability studies: The stability studies of the formulations 
were carried out as per ICH guidelines. The samples were 
observed for physical changes like color, flexibility, etc. 
RESULT AND DISCUSSION 
The compatibility between Verapamil Hydrochloride and 
the selected polymers were found out by using FTIR 
spectroscopy.  
The spectra of pure Verapamil Hydrochloride shows a 
distinctive peaks at 2990 cm-1  C-H stretching of methyl 
and methylene group, 2840 cm-1  C-H stretching of  
methoxy group, 2642.54 cm-1  N-H stretching of protonated 
amine, 2236 C=N cm-1  gr. Alkyl nitrile, 1591.90 cm-1  
stretching of  benzene ring and 1261.25 C=O stretching. 
Similar peaks are observed in the combinations of pure 
drug and mixture of selected polymers with slight 
variations in cm-1. That implies there is no interaction 
between drug and polymers.  
The physiochemical properties of the prepared 
formulations of Verapamil hydrochloride patches are 
tabulated. were thin, flexible, elastic, smooth and 
transparent/ translucent. The drug content uniformity of 
prepared formulations is in the following order: VH11> 
VH6> VH12> VH5> VH8> VH7> VH2> VH1> VH3> VH9> 
VH4> VH10. The values of drug content indicate that 
Verapamil Hydrochloride is uniformly distributed in the 
formulations. 
Scanning electron microscopic study was performed to 
know the surface characteristics of the prepared 
formulations (patches). The SEM photomicrographs 
suggest that the membranes VH4, VH5 and VH6 have 
shown plain, uniform and smooth surface, while, VH6 
formulation has shown relatively rough and dense surface 
than VH4 and VH5. 
Differential scanning calorimetry: Pure powder of 
Verapamil Hydrochloride showed a melting endotherm at 
148.240C. DSC test of VH5 showed a broad endotherm due 
to the existence of residual moisture in polymers. DSC 
thermogram of Verapamil Hydrochloride VH5 exhibits 
endothermic peaks at near to the pure drug temperature. 
This indicates that there is an absence of any interaction 
taking place between drug and polymers. 
The X-ray diffractograms of pure drug Verapamil 
Hydrochloride shows sharp peaks between the 5 to 28, 
VH5 dummy patch doesn’t show such peaks and VH5 patch 
containing drug shows peaks from 15 to 28. This 
indicates that the selected formulation having a drug in 
slight crystalline form. 
Water vapor transmission (WVT) through the rate 
controlling matrix patches determines the permeability 
characteristics. All the prepared matrix type of 
transdermal patches were permeable to water vapours 
The WVT rates for VH1, VH2, VH3, VH4, VH5, VH6, VH7, 
VH8, VH9, VH10, VH11, VH12, were 0.081, 0.042 , 0.016 , 
0.031, 0.028, 0.091,0.062, 0.018, 0.020, 0.022, 0.016 and 
0.059 respectively.  
The drug release studies from different patches were 
performed through the exercised rat abdominal skin and 
the results are listed. The cumulative amount of drug 
permeated per unit of surface area of the skin was plotted 
versus time, and the slope of the linear portion of the plot 
was calculated as the steady-state flux (JSS). The 
permeability coefficient (Kp), was then calculated with the 
following equation: 
Kp = JSS / CV 
Where CV is the total concentration of the drug in the 
donor compartment. 
In-vitro drug release studies were calculated for all the 
formulations and the percentage of drug permeations were 
calculated. VH1, VH2, VH3, VH4, VH5, VH6, VH7, VH8, VH9, 
VH10, VH11 and VH12 was 99.41, 96.65, 84.75, 90.71, 
83.25, 94.79, 70.96, 75.99, 66.41, 73.79, 63.14 and 60.98 at 
the end of 24th hour respectively. As the concentration of 
HPMC increases the rate of permeation increases in the 
case of 20% DMSO used, but in case of 40% DMSO is used 
as the concentration of CAP increases the rate of 
permeation increases. The drug permeation study shows 
that the % of drug permeation is more in formulations 
containing 20% of DMSO than 40% of DMSO. 
When primary skin irritation study is carried out on albino 
rabbits for the selected formulation VH6 indicates that 
there is no sign of erthyema or odema when compared 
with control patch. That indicates skin acceptability of 
these formulations for topical application. 
The prepared formulations are stable in nature. There is no 
effectiveness in color, plasticity and drug content.
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Table 2: Physicochemical properties of Verapamil HCl patches 
Formulation 
Physical 
appearance 
*Weight 
SD in + or - 
**Thickness 
*Drug 
content 
*Folding 
endurance 
VH1 + + 0.62(0.01) 0.147(0.00)15) 94.51 >295 
VH2 + + 0.75(0.01) 0.203(0.00)2) 95.15 >225 
VH3 + + 0.77(0.03) 0.217(0.00)41) 93.86 >15 
VH4 + + 0.76(0.02) 0.173(0.00)5) 91.93 >250 
VH5 + + 0.80(0.03) 0.25(0.003) 96.22 >270 
VH6 + + 0.73(0.01) 0.217(0.00)34) 96.65 >240 
VH7 + + 0.68(0.04) 0.147(0.00)1) 95.58 >295 
VH8 + + 0.77(0.02) 0.219(0.00)14) 95.79 >225 
VH9 + + 0.83(0.03) 0.240(0.00)23) 93.22 >15 
VH10 + + 0.80(0.01) 0.186(0.01) 91.28 >250 
VH11 + + 0.84(0.01) 0.249(0.00)24) 96.65 >270 
VH12 + + 0.78(0.02) 0.235(0.00)4) 96.44 >240 
The figure inside the parenthesis denotes the SD values  
*Average of three observations.  
**Average of five observations.  
++ indicates satisfactory, + - indicates not satisfactory.  
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Figure 1: FITR of Verapamil HCl 
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Figure 2: FTIR of mixture of Verapamil HCl , HPMC, CAP and EC 
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Figure 3:  SEM Photograph of VH4 patch 
 
 
Figure 4: SEM photograph of VH5 patch 
 
Figure 5: SEM photograph of VH6 patch 
 
 
Fig.6 DSC thermogram of Verapamil HCl
 
 
Figure 7: DSC thermogram of dummy patch VH5 
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Figure 8: DSC thermogram of drug loaded patch of VH5 
 
Figure 9: XRD diffraction of Verapamil HCl 
 
Figure 10: XRD diffraction of Verapamil HCl  Patch without drug 
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Figure 11:  XRD diffraction of Formulation VH 5 
 
Figure 12: In-vitro permeation of verapamil hydrochloride of all formulated patches through the rat  skin of 
formulation V5 to V8 
 
Figure 13: In-vitro permeation of verapamil hydrochloride of all formulated patches through the rat skin of 
formulation V1 to V4 
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Table 3: Skin irritation test of selected verapamil 
hydrochloride patch on rabbit 
Formulations Erythema                  Edema 
VH6 -- -- 
--: Nil, +: Mild, + +: Severe and +++: Very severe 
CONCLUSION 
In this research, attempts were made to formulate 
Verapamil Hydrochloride patches has been developed for 
the sustain transport of the drug action. This is done by 
using HPMC, CAP and EC as the rate retarding polymers 
using DMSO as the penetration enhancer. When those are 
subjected to evaluation, all the prepared transdermal 
patches were thin, elastic, smooth, flexible and 
transparent/ transculent. Uniformity and thickness were 
observed with the low SD values.  
In-vitro drug permeation study is performed using Franz 
diffusion cells where drug is permeated through rat skin. 
The data obtained was plotted to know the mechanism of 
drug release. The drug release study was extended for 24 
hrs. The incorporation of DMSO helped to enhance the 
penetration by detanglement of the lipid layer. Drug 
permeation is enhanced in the formulation containing high 
concentration of HPMC (VH1). The VH2 and VH6   helped in 
maintaining the rate of release at a constant level. Hence, a 
sustain release polymeric transdermal patch of verapamil 
hydrochloride was prepared which was able to deliver the 
drug at constant rate through the dermal barrier. 
Formulation containing 20% DMSO shows increased 
permeation than formulation containing 40% DMSO. Thus 
this study has shows potential results. 
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